Skip to main content
. Author manuscript; available in PMC: 2020 Aug 10.
Published in final edited form as: J Urol. 2019 Apr;201(4):728–734. doi: 10.1097/JU.0000000000000006

Table 1.

Baseline sociodemographic and facility characteristics.

Variables Whole cohort n, (%) No Treatment n, (%) Treatment n, (%) p-value
Continuous Variables
Age, years (Mean, SD) 76.24 (3.74) 77.48 (4.11) 75.85 (3.51) <0.001
PSA, ng/ml (Median, IQR) 5.6 (4.4–7.2) 5.8 (4.5–7.4) 5.6 (4.4–7.2) <0.001
Categorical Variables
Life Expectancy Groups <0.001
 66–69 & CCI=2 758 (3.15) 136 (2.31) 622 (3.42)
 70–74 & CCI≥1 4,485 (18.63) 755 (12.80) 3,730 (20.52)
 75–79 & all CCI 15,097 (62.70) 3,450 (58.48) 11,647 (64.07)
 ≥80 & all CCI 3,737 (15.52) 1,558 (26.41) 2,179 (11.99)
Race 0.0113
 White 20,944 (86.99) 5,040 (85.44) 15,904 (87.49)
 Black 2,218 (9.21) 606 (10.27) 1,612 (8.87)
 Other 627 (2.60) 153 (2.59) 474 (2.61)
 Unknown 288 (1.20) 100 (1.70) 188 (1.03)
Year of Diagnosis <0.001
 2004 2,989 (12.41) 509 (8.63) 2,480 (13.64)
 2005 2,877 (11.95) 493 (8.36) 2,384 (13.11)
 2006 3,104 (12.89) 579 (9.82) 2,525 (13.89)
 2007 3,154 (13.10) 570 (9.66) 2,584 (14.21)
 2008 2,750 (11.42) 632 (10.71) 2,118 (11.65)
 2009 2,292 (9.52) 662 (11.22) 1,630 (8.97)
 2010 2,112 (8.77) 648 (10.98) 1,464 (8.05)
 2011 2,072 (8.61) 690 (11.70) 1,382 (7.60)
 2012 1,433 (5.95) 538 (9.12) 895 (4.92)
 2013 1,294 (5.37) 578 (9.80) 716 (3.94)
Clinical T Stage 0.0001
 1 20,508 (85.18) 5,157 (87.42) 15,351(84.45)
 2 3,569 (14.82) 742 (12.58) 2,827 (15.55)
Insurance Type <0.001
 Private 2,948 (12.24) 665 (11.27) 2,283 (12.56)
 Medicaid 239 (0.99) 83 (1.41) 156 (0.86)
 Medicare 20,234 (84.04) 4,948 (83.88) 15,286 (84.09)
 Other Government 172 (0.71) 31 (0.53) 141 (0.78)
 Uninsured 90 (0.37) 42 (0.71) 48 (0.26)
 Unknown 394 (1.64) 130 (2.20) 264 (1.45)
Income 0.8551
 ≥$63,000 7,573 (31.45) 1,816 (30.78) 5,757 (31.67)
 $48,000–$62,999 6,636 (27.56) 1,650 (27.97) 4,986 (27.43)
 $38,000–$47,999 5,841 (24.26) 1,421 (24.09) 4,420 (24.32)
 ≤$37,999 4,005 (16.63) 1,007 (17.07) 2,998 (16.49)
 Unknown 22 (0.09) 5 (0.08) 17 (0.09)
Education Level* 0.1838
 ≥21% 3,495 (14.52) 903 (15.31) 2,592 (14.26)
 13–20.9% 5,903 (24.52) 1,354 (22.95) 4,549 (25.02)
 7–12.9% 8,421 (34.98) 2,053 (34.80) 6,368 (35.03)
 ≤6.9% 6,246 (25.94) 1,585 (26.87) 4,661 (25.64)
 Unknown 12 (0.05) 4 (0.07) 8 (0.04)
Great Circle Distance, Miles** 0.0933
 ≤12.4 15,081 (62.64) 3,590 (60.86) 11,491 (63.21)
 12.5–49.9 7,103 (29.50) 1,758 (29.80) 5,345 (29.40)
 ≥50 1,893 (7.86) 551 (9.34) 1,342 (7.38)
Urban/Rural Status 0.8117
 Metro 19,200 (79.74) 4,665 (79.08) 14,535 (79.96)
 Urban 3,899 (16.19) 991 (16.80) 2,908 (16.00)
 Rural 544 (2.26) 135 (2.29) 409 (2.25)
 Unknown 434 (1.80) 108 (1.83) 326 (1.79)
Facility Type <0.001
 Comprehensive Community 12,959 (53.82) 2,547 (43.18) 10,412 (57.28)
 Community Cancer Center 3,157 (13.11) 884 (14.99) 2,273 (12.50)
 Integrated Network Cancer Program 1,404 (5.83) 262 (4.44) 1,142 (6.28)
 Academic 6,552 (27.21) 2,206 (37.40) 4,346 (23.91)
 Other 5 (0.02) 0 (0) 5 (0.03)
Facility Case Volume 0.8814
 Very Low (≤20/year) 6,187 (25.70) 1,559 (26.43) 4,628 (25.46)
 Low (21–36/year) 5,896 (24.49) 1,413 (23.95) 4,483 (24.66)
 High (37–66/year) 6,089 (25.29) 1,444 (24.48) 4,645 (25.55)
 Very High (≥67/year) 5,905 (24.53) 1,483 (25.14) 4,422 (24.33)
Facility Location 0.1619
 New England 1,547 (6.43) 504 (8.54) 1,043 (5.74)
 Middle Atlantic 4,158 (17.27) 894 (15.16) 3,264 (17.96)
 South Atlantic 5,259 (21.84) 1,235 (20.94) 4,024 (22.14)
 East North Central 4,750 (19.73) 1,286 (21.80) 3,464 (19.06)
 East South Central 1,734 (7.20) 320 (5.42) 1,414 (7.78)
 West North Central 2,242 (9.31) 573 (9.71) 1,669 (9.18)
 West South Central 1,309 (5.44) 324 (5.49) 985 (5.42)
 Mountain 738 (3.07) 193 (3.27) 545 (3.00)
 Pacific 2,340 (9.72) 570 (9.66) 1,770 (9.74)
*

Percentage of adults within patient’s home zip code without a high school diploma quartiles.

**

Distance in miles between patient’s residence based on ZIP code centroid or city to street address of treating facility.